Green Cross Medical Science CEO Kim Yeongeun Increases Stake to 0.18% via Open Market Purchases

CEO Kim Yeongeun of Green Cross Medical Science purchased 3,000 common shares through open market transactions over three days from June 26 to 30, 2026.
The average acquisition price was 2,995 KRW, approximately 2.9% below the closing price of 3,085 KRW on the reporting date.
After the purchase, Kim's total holdings increased to 43,500 shares, representing 0.18% of total outstanding shares.
[AI Summary]The insider buying signals management confidence but the scale is negligible with limited short-term price impact. No changes to the company's capital structure or dividend policy.